NCT00545051View on ClinicalTrials.gov

A Study of Once Monthly Bonviva (Ibandronate) in Prevention of Glucocorticoid-Induced Osteoporosis.

PHASE4CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
Postmenopausal Osteoporosis
Interventions
DRUG

Placebo

po monthly for 12 months

DRUG

ibandronate

150mg po monthly for 12 months

Trial Locations (15)

10100

Jyväskylä

13530

Hämeenlinna

15110

Lahti

20100

Turku

33100

Tampere

33101

Tampere

40100

Jyväskylä

70211

Kuopio

90029

Oulu

90100

Oulu

00100

Helsinki

00290

Helsinki

00350

Helsinki

05800

Hyvinkää

01300

Vantaa

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Hoffmann-La Roche

INDUSTRY